Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Call for Quality: Revamped GMP Initiative Stresses Cost Savings

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA is kicking off phase two of its 21st Century GMP initiative using new authorities and funding under the FDA Safety & Innovation Act. To encourage investment in quality manufacturing systems, the agency is highlighting the cost savings seen by early adopters of quality systems..

Advertisement

Related Content

FDA Warning On Data Integrity: “Sometimes Lawyers Become Too Clever For Their Own Good”
FDA Warning On Data Integrity: “Sometimes Lawyers Become Too Clever For Their Own Good”
FDA Warning On Data Integrity: “Sometimes Lawyers Become Too Clever For Their Own Good”
FDA/EMA Bioequivalence Collaboration Is Narrow In Scope, Wide In Reach
FDA’s Woodcock to Head Office of Pharmaceutical Quality; New Details Emerge
FDA GMP “Surveillance” Will Link Quality, Compliance Information To Inspections
Culture Clash: FDA Tries to Re-Educate Indian Firms on Processes and Accurate Reporting
FDA Quality Profiling: Agency Hopes to Channel Corporate Attention (And Money) To Quality Systems
FDA Could Release GMP Data To Prod Manufacturing Improvements
DoJ and GMPs: A Prosecutor’s Take on Enforcing Product Quality

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS076386

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel